New macrolactins from a marine Bacillus sp. Sc026

Area of Science:

• Marine microbiology
• Natural product chemistry
• Antimicrobial drug discovery

Background:

• Marine microorganisms, particularly bacteria like Bacillus sp., are a rich source of novel bioactive compounds.
• Macrolactins are a class of polyketide metabolites with diverse biological activities, including antimicrobial properties.
• The chemical diversity and bioactivity of marine-derived Bacillus species warrant further investigation for potential therapeutic agents.

Purpose of the Study:

• To isolate and characterize bioactive compounds from the marine Bacillus sp. Sc026.
• To identify new macrolactin derivatives with potential antibacterial properties.
• To evaluate the antimicrobial efficacy of the isolated compounds against pathogenic bacteria.

Main Methods:

• Bioassay-guided fractionation of the ethyl acetate (EtOAc) extract from Bacillus sp. Sc026 culture broth.
• Structure elucidation of isolated compounds using comprehensive spectral data analyses (e.g., NMR, MS) and comparison with literature data.
• In vitro antibacterial activity testing against Bacillus subtilis and Staphylococcus aureus.

Main Results:

• Isolation of the known compound macrolactin F (1).
• Characterization of two novel compounds: 7-O-succinyl macrolactin F (2) and 7-O-succinyl macrolactin A (3).
• Compounds 1-3 exhibited notable antibacterial activity against both Bacillus subtilis and Staphylococcus aureus.

Conclusions:

• The marine Bacillus sp. Sc026 produces macrolactins with antibacterial potential.
• The novel succinyl derivatives, 7-O-succinyl macrolactin F and 7-O-succinyl macrolactin A, represent new additions to the macrolactin family.
• These findings highlight the potential of marine-derived Bacillus species as a source for developing new antibacterial agents.